|
GFPT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.955000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.241800E-02 |
| Normal-vs-Stage2 |
7.235000E-01 |
| Normal-vs-Stage3 |
9.606400E-02 |
| Normal-vs-Stage4 |
3.540000E-01 |
| Stage1-vs-Stage2 |
5.242000E-01 |
| Stage1-vs-Stage3 |
2.732400E-02 |
| Stage1-vs-Stage4 |
1.941970E-01 |
| Stage2-vs-Stage3 |
9.002100E-02 |
| Stage2-vs-Stage4 |
3.134400E-01 |
| Stage3-vs-Stage4 |
8.746800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.776000E-01 |
| Normal-vs-AfricanAmerican |
8.503200E-01 |
| Normal-vs-Asian |
4.312400E-01 |
| Caucasian-vs-AfricanAmerican |
6.947800E-01 |
| Caucasian-vs-Asian |
2.364200E-01 |
| AfricanAmerican-vs-Asian |
4.243400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.425800E-04 |
| Normal-vs-Female |
9.657300E-03 |
| Male-vs-Female |
1.000200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.288600E-01 |
| Normal-vs-Extreme_Weight |
2.22890000000087E-05 |
| Normal-vs-Obese |
3.691200E-01 |
| Normal-vs-Extreme_Obese |
1.526970E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.474200E-02 |
| Normal_Weight-vs-Obese |
5.895400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.452800E-01 |
| Extreme_Weight-vs-Obese |
5.063000E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.321200E-01 |
| Obese-vs-Extreme_Obese |
7.716300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.180380E-01 |
| Normal-vs-Age(41-60Yrs) |
8.022200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.767600E-02 |
| Normal-vs-Age(81-100Yrs) |
4.017800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.108630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.301700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.436200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.713500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.919000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.995400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.16989999999306E-05 |
| Normal-VS-Type2 PRCC |
3.832800E-01 |
| Normal-VS-KIRP CIMP |
5.355100E-03 |
| Normal-VS-Unclassified PRCC |
5.482800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.040700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.555900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.077200E-03 |
| Type2 PRCC-VS-KIRP CIMP |
8.123500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.883200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.020600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.773800E-01 |
| Normal-vs-N1 |
5.040200E-02 |
| Normal-vs-N2 |
2.736800E-01 |
| N0-vs-N1 |
3.025900E-02 |
| N0-vs-N2 |
3.674000E-02 |
| N1-vs-N2 |
9.540000E-01 |
|
|
